the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Spike in dengue cases; no death reported

PUTRAJAYA: The number of dengue fever cases has increased to 3,971 in the 3rd Epidemiological Week (ME03) 2024, from Jan 14 to 20, compared with 3,525 cases reported in the previous week.

Health director-general Datuk Dr Muhammad Radzi Abu Hassan said that no deaths due to dengue fever complications were reported during the period.

In terms of the number of hotspot localities, he said the number has dropped to 127 compared with 136 the previous week, with the highest number recorded in Selangor with 105 localities, followed by the Federal Territory of Kuala Lumpur and Putrajaya (13), Perak (three) and Negeri Sembilan (two).

For chikungunya surveillance, Dr Muhammad Radzi said there was one case recorded in ME03 with the cumulative number of cases to date being two cases while no chikungunya outbreak was reported.

“For Zika surveillance, a total of 97 blood samples were screened for Zika and the results were all negative,“ he said in a statement today. –Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings